M. Bradley Drummond, MD, MHS
Chapel Hill, NC, USA
Michael Bradley (Brad) Drummond is an Associate Professor of Medicine in the Division of Pulmonary Diseases and Critical Care Medicine at the University of North Carolina, Chapel Hill School of Medicine where he also serves as Director of the Obstructive Lung Diseases Clinical and Translational Research Center.
Dr. Drummond’s clinical expertise includes COPD, alpha-1 antitrypsin deficiency, and smoking cessation. With an expertise in epidemiology and clinical trial design, he has focused his translational and clinical research on understanding the pattern and risk factors for lung function progression in smokers as well as HIV-infected individuals. His primary project is a National Heart Lung and Blood Institute-funded study of a novel biomarker in the blood and lungs of individuals with or at-risk for COPD and examining the role of vitamin D on levels of this biomarker.
He completed his medical degree from the University of Texas Southwestern School of Medicine followed by a residency in internal medicine and a fellowship in pulmonary and critical care medicine at Johns Hopkins Hospital and School of Medicine, where he served as chief resident.
Dr. Drummond is active with the American College of Chest Physicians and a Fellow and Mentor with the American Thoracic Society. He is also a member of the COPD Foundation’s Medical and Scientific Advisory Board.
Dr. Drummond has served as a reviewer for many peer-reviewed journals including the New England Journal of Medicine, the Journal of the American Medical Association, the American Journal of Respiratory and Critical Care Medicine, Thorax and the Annals of Internal Medicine where he was recognized as being in the “Top 10 Percent of Reviewers.” He has served as an associate editor for BMC Pulmonary Medicine and Chronic Obstructive Pulmonary Diseases: Journal of COPD and is currently on the Editorial Board of Annals of the American Thoracic Society. Before becoming an Editor for Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation, he served on its Editorial Board from its inception in 2014.
MARIA ROSA FANER, PhD
Maria “Rosa” Faner is the Serra Hunter Professor of Immunology at the Universitat de Barcelona, Spain.
Dr. Faner’s primary research focus is understanding the clinical and immunological heterogeneity of chronic respiratory diseases such as COPD. Within this framework, her main areas of expertise relate to the vital lung function trajectories in COPD, the application of network medicine tools to study the heterogeneity of COPD, and the immunological aspects of COPD both at the molecular and cellular levels.
Dr. Faner holds a Master of Science in biology and a PhD in immunology from the University Autónoma de Barcelona, Spain. Her completed fellowships include: the Catalan Ministry of Science student fellowship, the Beatriu de Pinos Blood and Tissue Bank (Barcelona) post-doctoral fellowship, the Miguel Servet Research Fellowship with the Spanish National Health System, a research fellowship with the European Respiratory Society and the Dyason Research Fellowship at the University of Melbourne.
She has also served as a post-doctoral researcher with the Fundació Privada Clinic in Barcelona, CIMERA in Illes Balears, and CIBERES in Barcelona and as a visiting scientist at the Channing Division of Network Medicine at Harvard University, Boston.
Dr. Faner is active with the European Respiratory Society and has been a frequent invited presenter at the Society’s annual congress in addition to presenting at the American Thoracic Society’s International Conference, among others.
Dr. Faner has published extensively in the world’s top cited journals with extensive international collaboration.
Ken Kunisaki, MD, MS
Minneapolis, MN, USA
Ken Kunisaki, MD, MS, is currently a staff physician at the Minneapolis Veterans Affairs (VA) Health Care System and Associate Professor of Medicine in the Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine at the University of Minnesota.
Dr. Kunisaki’s research interests are primarily in clinical trials, observational cohort studies, and international team-based science. COPD studies have been a primary focus throughout his investigative career, ranging from epidemiologic investigations to early-phase, hypothesis-generating pilot studies to multi-center randomized controlled trials. His other National Institutes of Health (NIH) and VA-funded research areas include sleep apnea, respiratory infections (such as influenza and COVID-19), and HIV-associated lung and sleep disorders.
Dr. Kunisaki received his medical degree from Ohio State University, followed by residency (internal medicine and pediatrics), fellowship (adult pulmonary and critical care medicine) and a Master of Science in Clinical Research degree at the University of Minnesota, where he remains on faculty. His full-time clinical practice is at the Minneapolis VA, where he directs the COPD Case Management Program, performs navigational bronchoscopy procedures, and attends on the pulmonary consultation teaching service.
Dr. Kunisaki is a fellow of the American Thoracic Society, and his other professional activities include serving on clinical trial data safety and monitoring boards and serving on grant review study sections for the NIH and VA.
Prior to becoming an Editor for Chronic Obstructive Pulmonary Diseases: the Journal of the COPD Foundation, Dr. Kunisaki served on the journal’s editorial board since its founding in 2014. He is also on the editorial board of HIV Medicine, and he is a regular reviewer for peer-reviewed medical journals in general medicine, respiratory medicine, sleep medicine, and HIV and infectious diseases.
Fanny Wai San Ko, MD
Fanny Wai San Ko, MD, is a specialist respiratory physician consultant in the Department of Medicine and Therapeutics at Prince of Wales Hospital in Hong Kong. She is also the Honorary Clinical Associate Professor of the Faculty of Medicine at the Chinese University of Hong Kong.
Dr. Ko’s main research interest is in asthma and COPD. She is currently studying the outcome of patients with asthma and COPD, including those with an overlap of the diseases. In addition, she is performing research on exhaled nitric oxide and the microbiome of asthma patients.
Dr. Ko graduated from the Chinese University of Hong Kong. After her graduation, she completed full training in internal and respiratory medicine at the Prince of Wales Hospital in Hong Kong. With the support of the Croucher Foundation Scholarship and the Hong Kong Lung Foundation Fellowship, she also completed a year of research training in the Woolcock Institute of Medical Research at the University of Sydney in Australia.
Dr. Ko is currently a member of the Scientific Committee of the Global Initiative for Asthma (GINA), Vice-chairman of Hong Kong Lung Foundation and Medical Advisor of the Hong Kong Asthma Society. In addition, she is a Past President of the Hong Kong Thoracic Society.
Dr. Ko has published more than 160 papers in peer reviewed journals. She has been the Senior Editor of Respirology since 2013 and an Associate Editor for the International Journal of Tuberculosis and Lung Disease since 2019.
In addition, Dr. Ko has served as a reviewer for the American Journal of Respiratory and Critical Care Medicine, Thorax, Clinical Experimental Allergy, Respirology, BMC Pulmonary Medicine, the International Journal of Tuberculosis and Lung Disease, Respiratory Medicine, Respiration, International Archives of Allergy and Immunology and PLOS One.
Barry Make, MD
Denver, CO, USA
Dr. Barry Make is Co-Director of the COPD Program and Director of Pulmonary Rehabilitation and Respiratory Care at National Jewish Health. He is also a Professor of Medicine in the Division of Pulmonary Sciences and Critical Care Medicine at the University of Colorado School of Medicine.
Dr. Make's primary interest is clinical research on the management and outcomes of chronic obstructive pulmonary disease (COPD). Dr. Make has been an investigator on multiple grants from the National Heart, Lung, and Blood Institute including the Genetic Epidemiology of COPD study.
Dr. Make also sees adult outpatients with COPD and related pulmonary disorders at National Jewish Health. He has been recognized as one of the Castle Connolly’s Top Doctors in the United States for the past 12 years.
Dr. Make is a Fellow of the American College of Chest Physicians, and the American Association of Cardiovascular and Pulmonary Rehabilitation. He is a member of the American Thoracic Society, American Association for Respiratory Care, and the Colorado Trudeau Society. He regularly lectures internationally on COPD.
Dr. Make’s publications include over 250 articles, books, book chapters and web-based audiovisual educational program on COPD and pulmonary medicine.
Prior to joining Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation as an Editor, Dr. Make has served on the Editorial Boards of the American Review of Respiratory Disease, Respiratory Medicine, the Journal of Cardiopulmonary Rehabilitation and Respiratory Homecare. He has also served as a reviewer for numerous peer-reviewed journals including CHEST, the American Journal of Respiratory and Critical Care Medicine, Respiratory Care, and the European Respiratory Journal. He served as an Editor for COPD: Journal of Chronic Obstructive Pulmonary Disease from 2003-2013.
Valerie Press, MD, MPH
Chicago, IL, USA
Valerie Press is an Associate Professor of Medicine and Pediatrics and Medical Director of the Care Transitions Clinic at the University of Chicago. Dr. Press received her medical degree and Master of Public Health in health management and policy degree at the University of Michigan in Ann Arbor. She completed her internal medicine and pediatrics residency training and health services research fellowship training at the University of Chicago.
Dr. Press' research is focused on developing, testing, and implementing patient and system level interventions to improve the quality and value of care for patients with chronic lung disease across care transition settings. She currently serves as principal investigator for a Research Project grant (R01) from the National Institutes of Health’s National Heart, Lung, and Blood Institute and as principal investigator on an Innovation Award from the American Lung Association, both focused on improving care for patients with COPD by reducing revisits to the emergency department and/or hospital after a hospitalization for COPD exacerbations.
Dr. Press is a Fellow of the American Thoracic Society (ATS), the American College of Physicians, and the American Academy of Pediatrics, and she is a Senior Fellow of the Society of Hospital Medicine. She is active with each of these societies and the COPD Foundation, serving on the Advisory Board for the Foundation’s health care provider initiative, PRAXIS—Prevent and Reduce COPD Admissions Through Expertise and Innovations Sharing. Dr. Press received the ATS’ Early Career Achievement Award in 2020.
Dr. Press has authored or coauthored nearly 100 manuscripts in peer-reviewed journals. In addition to serving as an Editor of Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation, Dr. Press is also an Associate Editor for the Journal of General Internal Medicine. Dr. Press serves on the editorial boards of Annals of American Thoracic Society, CHEST (COPD team), and Frontiers in Medicine-Pulmonary Medicine (Review Editor).
Nirupama Putcha, MD, MHS
Baltimore, MD, USA
Nirupama (Niru) Putcha, MD, MHS, is an Assistant Professor of Medicine in the Division of Pulmonary and Critical Care Medicine at Johns Hopkins University School of Medicine.
Dr. Putcha’s clinical expertise includes obstructive lung diseases, specifically COPD. She is a member of the Johns Hopkins Bridging Research, Lung Health and the Environment (BREATHE) Center which seeks to understand the intersection between the environment and health outcomes in obstructive lung diseases in Baltimore. As a member of the BREATHE center she has focused her clinical research on understanding the importance of environmental exposures including allergens and pollutants as well as comorbid chronic disease on health outcomes in individuals with COPD. Her primary projects seek to look at allergen sensitization and exposure and risk for adverse outcomes in COPD, as well as the role of home environmental exposures on risk for readmission in individuals with COPD recently hospitalized for exacerbations.
She completed her medical degree from the University of Alabama at Birmingham followed by residency in internal medicine at the Hospital of the University of Pennsylvania and fellowship in pulmonary and critical care medicine at Johns Hopkins, where she completed a Masters in Epidemiology at the Johns Hopkins Bloomberg School of Public Health.
Dr. Putcha is a member of the American Thoracic Society, where she is active in the Clinical Problems and the Environmental Occupational and Public Health Assemblies. She also serves as faculty in the ATS “Methods in Epidemiologic, Clinical, and Operations Research (MECOR)” program course in India.
Dr Putcha has served as a reviewer for many peer-reviewed journals including the American Journal of Respiratory and Critical Care Medicine, Thorax, Annals of the American Thoracic Society, and Chest. She has served as Associate Editor for BMC Pulmonary Medicine. Before becoming an Editor for Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation, she served on its Editorial Board from its inception in 2014.
James D. Crapo, MD
Denver, CO, USA
Dr. James Crapo is currently a Professor of Medicine at the University of Colorado-Denver and National Jewish Health where he also served as the Chairman of the Department of Medicine and Executive Vice President for Academic Affairs from 1996 until 2004. In addition, he served as Chief of the Division of Pulmonary and Critical Care Medicine at Duke University for 17 years, following training at the Los Angeles Harbor General Hospital, Duke University and the National Institute of Environmental Health Sciences.
Dr. Crapo maintains an active research program focused in two areas: (1) Development of metalloporphyrin antioxidant mimetics as a new therapeutic in the fields of cancer radiation therapy, idiopathic pulmonary fibrosis, organ transplantation, and neurologic diseases, and (2) Serving as co-principal investigator of COPDGene, a National Heart Lung and Blood Institute (NHLBI)-funded multi-center project to follow a cohort of more than 10,000 individuals who have a significant smoking history and are at risk for or have COPD.
Dr. Crapo is a former President of the American Thoracic Society and the Fleischner Society. He is a Fellow of the American College of Physicians and the American College of Chest Physicians. He is a member of the American Society of Clinical Investigation and the Association of American Physicians. Dr. Crapo has served as the Chair of the National Heart Lung and Blood Institute (NHLBI) Pulmonary Disease Advisory Committee and as a Member of Council for the NHLBI, and he currently serves as a member of the NHLBI Board of External Advisors.
Dr. Crapo has authored over 300 published peer-reviewed articles and 48 book chapters. He is the author of 10 pulmonary textbooks.
Prior to becoming the Editor in Chief of Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation, he served as Editor of COPD: Journal of Chronic Obstructive Pulmonary Disease for 10 years and as an Associate Editor for Experimental Lung Research and the American Journal of Respiratory Cell and Molecular Biology. He has also served on the Editorial Boards of the American Review of Respiratory Diseases, Inhalation Toxicology, the Journal of Allergy and Clinical Immunology and the American Journal of Physiology: Lung Cellular and Molecular Physiology.